Project Grant R01HL173155
Award Date
8/1/25
Completion Date
5/31/30
Dollars Obligated
$689K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research provides $130,065 in funding to The Regents of the University of California, San Francisco (UCSF) to conduct research and mentorship activities focused on optimizing the treatment and evaluation of blood pressure for patients in safety net health systems. The key objectives are to: 1) Conduct systematic economic analyses of the costs associated with...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,321,108 Project Grant under CFDA 93.837 (Cardiovascular Diseases Research) to New York University School of Medicine to conduct transdisciplinary implementation research on a strategy called PT4A. PT4A integrates peer-based medication delivery, peer coaching, and health information technology to improve medication adherence and reduce blood pressure among patients with uncontrolled hypertension in Western Kenya. The study aims to...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA Program 93.837 - Cardiovascular Diseases Research, provides $708,678 to Wake Forest University Health Sciences to conduct a Sequential Multiple Assignment Randomized Trial (SMART). The study aims to determine the most effective interventions to reduce food insecurity and improve adherence to hypertension treatment among patients with uncontrolled hypertension and food insecurity. The...
The federal Project Grant award R01HL176882, totaling $734,722.00, was provided by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to the University of Alabama at Birmingham (UAB). The award will fund a randomized clinical trial to assess the efficacy of disseminating systolic blood pressure polygenic risk scores (SBP PRS) on SBP control, adherence to a healthy lifestyle, and cardiometabolic profile among 300 hypertensive young and middle-aged U.S....
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $161,000.00 to Duke University to plan a clinical trial evaluating an implicit bias mitigation training curriculum for primary care clinicians. The goal is to determine if the "Reaching Equity" training can increase use of implicit bias mitigation skills by clinicians and reduce racial disparities in hypertension...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $362,250 to Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to evaluate whether treating elevated blood pressure in the inpatient setting impacts patient outcomes. The project, titled "Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes: The ACT-BP Pilot," aims to...
The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $648,073 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to The Johns Hopkins University to conduct the ADHINCRA study, which aims to address hypertension care in Ghana and Nigeria. The project will implement a multilevel intervention that integrates home-based blood pressure monitoring, team-based care with nurse training, and simplified hypertension treatment protocols to improve blood pressure control in...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will support a $691,299 hybrid effectiveness-implementation trial to evaluate the impact of provider referrals to a remotely delivered physical activity intervention for Latina adolescents. The intervention, called "Chicas Fuertes 2," will leverage mobile technologies like wearable trackers, personalized text messages, and social media to promote...
This federal Project Grant award with ID R61HL172269, totaling $724,064.00, was provided by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award will fund the development and evaluation of a multi-level, integrated intervention called "HTN-Urban" to improve hypertension control among adults living in urban Vietnam. Key components of the intervention include a storytelling program, home blood pressure...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $162,000 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Connecticut. The grant will fund a 12-week proof-of-concept study testing a technology-delivered mindful walking intervention to reduce stress, increase physical activity, and lower blood pressure in Black women with hypertension. The project aims to address disparities in hypertension and physical activity rates among...